Search PubMedSearch

PubMed · 7972991

Knemometry.

Abstract

Knemometry provides a powerful tool for observation of short-term growth patterns. Failure of response to growth-promoting therapies in the short term predicts a poor statural response, but the relationship of the lower leg growth suppression seen with oral and inhaled corticosteroids, and the clinical implications in the longer term, remain unclear. The accumulating evidence suggests that there are measurable biochemical and clinical effects with some inhaled corticosteroids (e.g. beclomethasone dipropionate and budesonide), when given at the upper end of the recommended conventional dose range (18) and for long-term prophylaxis, and certainly at the higher starting doses. It is imperative, therefore, that all children receiving inhaled corticosteroids should have their growth monitored carefully and that the lowest effective dose of corticosteroid should be used.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C MacKenzie. 1994. Knemometry.. https://doi.org/10.1016/s0954-6111(05)80039-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].

In a randomized, double-blind, double-dummy, cross-over study the efficacy and safety of inhaled salmeterol 50 mcg (b.i.d.) was compared with oral salbutamol controlled release 8 mg (b.i.d.). Fifty-nine patients with moderate asthma were randomized to two four-week periods of treatment with a two-week washout period. During the study period the patients were allowed to use inhaled Salbutamol on a prn. basis. Inhaled steroids, if any, were continued. On diary cards patients recorded peak expiratory flow rate (PEFR) morning and evening before medication, asthma symptom score, and use of inhaled salbutamol. Salmeterol was more effective than salbutamol CR in decreasing daily symptoms (p = 0.001) and increasing morning-PEFR (p = 0.004). Salmeterol resulted in significantly more days without symptoms (p = 0.0004) and days and nights without need for rescue medication (p = 0.01 and p = 0.01). Salmeterol was better tolerated than salbutamol CR.

Administration, Inhalation